Cost-effective therapy for hypertension

Western Journal of Medicine

Volumn 164, Issue 4, 1996, Pages 303-309

  Barrie, William ^a,b,c  

^a School of Medicine ^*

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CARDIOVASCULAR AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; INSULIN; LIPID; PLACEBO;

ANTIHYPERTENSIVE THERAPY; CLINICAL TRIAL; CORONARY ARTERY DISEASE; COST CONTROL; COST EFFECTIVENESS ANALYSIS; DIABETES MELLITUS; DRUG COST; DRUG USE; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; HYPOKALEMIA; INSULIN RESISTANCE; MORTALITY; PRACTICE GUIDELINE; QUALITY OF LIFE; REVIEW; SEXUAL DYSFUNCTION; STROKE;

ANTIHYPERTENSIVE AGENTS; COST CONTROL; COST-BENEFIT ANALYSIS; DIABETES MELLITUS; DRUG COSTS; DRUG UTILIZATION REVIEW; HUMANS; HYPERTENSION; MICHIGAN; PRACTICE GUIDELINES; QUALITY OF LIFE; UNITED STATES;

EID: 0030009580     PISSN: 00930415     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (36)

1. Joinl National Committee on Detection. Evaluation, and Treatment of High Blood Pressure The Fifth Report of the Joint National Committee on Detection. Evaluation, and Treatment of High Blood Pressure. Arch Intern Med 1993: 153 154-183
2. Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. The 1988 Report of the Joint National Committee on Detection. Evaluation, and Treatment of High Blood Pressure. Arch Intern Med 1988, 148:1023-1038
3. Carruthers SG, Larochelle P, Haynes RB. Patrasovits A, Schiffrm EL Report of the Canadian Hypertension Society Concensus Conference - 1 Introduction Can Med Asvoc J 1993; 149:289-293
4. Sever P, Beevers G, Bulpitt C. et al: Management guidelines in essential hypertension: Report of the second working party of the British Hypertension Society. BMJ 1993; 306:983-987
5. Collins R, Peto R, MacMahon S, et al. Epidemiology: Blood pressure, stroke, and coronary heart disease - Pt 2. Short-term reductions in blood pressure: Overview of randomised drug trials in their epidemtological context. Lancet 1990; 335:827-838
6. SHEP Cooperative Research Group: Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension - Final results of the Systolic Hypertension in the Elderly Program (SHEP). JAMA 1991; 265:3255-3264
7. Dahlöf B, Lindhotm LH, Hansson L, Scherstén B. Ekbom T, Wester PO: Morbidity and mortality in the Swedish Trial in Old Patients with Hypertension - STOP-Hypertension. Lancet 1991; 338:1281-1285
8. MRC Working Party. Medical Research Council trial of treatment of hypertension in older adults: Principal results. BMJ 1992; 304:405-412
9. Hebert PR, Moser M, Mayer J. Glynn RJ. Hennekens CH: Recent evidence on drug therapy of mild to moderate hypertension and decreased risk of coronary heart disease Arch Intern Med 1993; 153:578-581
10. Insua JT, Sacks HS, Lau TS. et al: Drug treatment of hypertension in the elderly: A meta-analysis. Ann Intern Med 1994; 121:355-362
11. Psaty BM, Savage PJ, Tell GS, et al: Temporal patterns of antihypertensive medication use among elderly patients - The Cardiovascular Health Study. JAMA 1993; 270:1837-1841
12. Aucott JN, Taylor AL, Wright JT Jr. et al: Developing guidelines for local use: Algorithms for cost-efficient outpatient management of cardiovascular disorders in a VA medical center. Jt Comm J Qual Improv 1994; 20:17-32
13. Wiklund I: Quality of life and cost-effectiveness in the treatment of hypertension. J Clin Pharm Ther 1994; 19:81-87
14. McCorvey E Jr, Wright JT Jr. Culbert JP, McKenney JM, Proctor JD, Annett MP: Effect of hydrochlorothiazide, enalapril, and propranolol on quality of life and cosnitive and motor function in hypertensive patients. Clin Pharm 1993; 12:300-305
15. Neaton JD, Grimm RH Jr. Prineas RJ. et al: Treatment of mild hypertension study - Final results. JAMA 1993; 270:713-724
16. Wassertheil-Smoller S. Blaufox MD, Oberman A. et al: Effect of antihypertensives on sexual function and quality of life: The TAIM study Ann Intern Med 1991; 114:613-620
17. Prisant LM, Carr AA, Bottini PB, Solursh DS, Solursh LP: Sexual dysfunction with antihypertensive drugs. Arch Intern Med 1994; 154:730-736
18. Materson BJ, Reda DJ, Cushman WC, et al: Single-drug therapy for hypertension in men - A comparison of six antihypertensive agents with placebo in The Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents N Engl J Med 1993; 328:914-921
19. Moser M: Can the cost of care be contained and quality of care maintained in the management of hypertension? Arch Intern Med 1994; 154:1665-1672
20. Torvik D, Madsbu H: An open one-year comparison of doxazosin and prazosin for mild to moderate essential hypertension. Am J Cardiol 1987; 59:68G-72G
21. Warram JH, Laffel LM, Valsania P, Christlieb AR, Krolewski AS: Excess mortality associated with diuretic therapy in diabetes mellitus. Arch Intern Med 1991, 151:1350-1356
22. Dawson KG, McKenzie JK, Ross SA, Chiasson JL, Harnet P: Report of the Canadian Hypertension Society Consensus Conference: 5. Hypertension and diabetes. Can Med Assoc J 1993; 149:821-826
23. Gurwitz JH, Bohn RL, Glynn RJ, Monane M, Mogun H. Avom J. Antihypertensive drug therapy and the initiation of treatment for diabetes meltitus. Ann Intern Med 1992; 318:273-278
24. Systolic Hypertension in the Elderly Program Cooperative Research Group: Implications of the Systolic Hypertension in the Elderly Program. Hypertension 1993; 21:335-343
25. Fuller JH: Hypertension and diabetes - Epidemiologic aspects as a guide to management. J Cardiovasc Pharmacol 1993; 21(suppl 2):S63-S66
26. Slataper R, Vicknair N, Sadler R, Bakris GL: Comparative effects of different antihypenensive treatments on progression of diabenc renal disease. Arch Intern Med 1993; 153:973-980
27. Lacourcière Y, Nadeau A. Poirier L. Tancrède G: Captopril or conventional therapy in hypertensive type II diabetics - Three-year analysis. Hypertension 1993: 21(pt 1):786-794
28. Hoes AW, Grobbee DE, Peet TM. Lubsen J: Do non-potassium-sparing diuretics increase the risk of sudden cardiac death in hypertensive patients? - Recent evidence. Drugs 1994; 47:711-733
29. Siscovick DS, Raghunathan TE, Psaty BM, et al: Diuretic therapy for hypertension and the risk of primary cardiac arrest. N Engl J Med 1994; 330: 1852-1857
30. Frohlich ED, Apstein C, Chobanian AV, et al: The heart in hypertension N Engl J Med 1992; 327:998-1008
31. Wikstrand J, Warnold I, Olsson G, Tuomilehto J, Elmfeldt D. Berglund G. Primary prevention with metoprolol in patients with hypertension. JAMA 1988, 259 1976-1982
32. Hanneduuche T, Landais P, Goldfarb B. et al: Randomized controlled trial of enalapril and beta blockers in non-diabetic chronic renal failure. BMJ 1994; 309:833-837
33. Edelson JT, Weinstein MC, Tosteson AN, Williams L. Lee TH, Goldman L: Long-term cost-effectiveness of various initial monotherapies for mild to moderate hypertension. JAMA 1990; 263:407-413
34. Hilleman DE, Mohiuddin SM, Lucas BD Jr, Stadmg JA, Stoysich AM. Ryschon K: Cost-minimization analysis of initial antihypertensive therapy in patients with mild-to-moderate essential diastolic hypertension. Clin Ther 1994; 16:88-102
35. Fletcher AE, Bulpitt CJ How far should blood pressure be lowered? N Engl J Med 1994; 326:251-254
36. Farnett L, Mulrow CD, Linn WD, Lucey CR, Tuley MR: The J-curve phenomenon and the treatment of hypertension - Is there a point beyond which pressure reduction is dangerous? JAMA 1991; 265:489-495